NEW YORK (GenomeWeb News) – Illumina disclosed in its quarterly filing with the US Securities and exchange Commission that it paid a total consideration of $95.5 million for its acquisition of BlueGnome in July. At the time, Illumina didn't disclose the purchase price.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.